The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current ...

First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable ...

The U.S. FDA has granted de novo clearance for Epiminder Pty. Ltd.’s Minder implantable device for continuously monitoring brain activity in patients with epilepsy.

Many families face the challenge of drug-resistant epilepsy, questioning the transition from medication to surgery.

Electroencephalogram (EEG) is a method used to measure and visualize spontaneous electrical activity within the brain. Electrical impulses are the main form of signaling found within the brain; ...

First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable ...